In vitro- forsøg og dyremodeller har vist, at abatacept modulerer det T- lymfocytafhængige antistofrespons og inflammation.
Studies in vitro and in animal models demonstrate that abatacept modulates T lymphocyte-dependent antibody responses and inflammation.